You are currently browsing the archives for 26 October 2015.
Displaying 1 entry.

Teva and Sanofi-Aventis SA currently own on the market s best-selling drug Copaxone.

Teva and Sanofi-Aventis SA currently own on the market ‘s best-selling drug Copaxone, which had more than $ 2.8 billion in sales in 2009. Biogen Avonex also had more than $ 2 billion in annual revenues, while Bayer Betaseron and Merck’s Rebif had more than $ 1 billion in sales.

While many existing drugs through a daily injection or infusion should be administered, the medication side effects such as flu-like symptoms. The drugs orally taken Gilenya is used in Europe are prescribed at a 0.5-milligram daily dose to treat patients with highly active relapsing-remitting multiple sclerosis.